Janus kinase inhibitors and allogeneic stem cell transplantation for myelofibrosis
about
Critical appraisal of the role of ruxolitinib in myeloproliferative neoplasm-associated myelofibrosisMPD-RC 101 prospective study of reduced-intensity allogeneic hematopoietic stem cell transplantation in patients with myelofibrosisOutcomes of Allogeneic Hematopoietic Cell Transplantation in Patients with Myelofibrosis with Prior Exposure to Janus Kinase 1/2 Inhibitors.Allo-SCT for myelofibrosis: reversing the chronic phase in the JAK inhibitor era?Setting Appropriate Goals for the Next Generation of Clinical Trials in Myelofibrosis.Haploidentical hematopoietic stem cell transplantation in a myelofibrosis patient with primary graft failure.
P2860
Janus kinase inhibitors and allogeneic stem cell transplantation for myelofibrosis
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
Janus kinase inhibitors and allogeneic stem cell transplantation for myelofibrosis
@ast
Janus kinase inhibitors and allogeneic stem cell transplantation for myelofibrosis
@en
type
label
Janus kinase inhibitors and allogeneic stem cell transplantation for myelofibrosis
@ast
Janus kinase inhibitors and allogeneic stem cell transplantation for myelofibrosis
@en
prefLabel
Janus kinase inhibitors and allogeneic stem cell transplantation for myelofibrosis
@ast
Janus kinase inhibitors and allogeneic stem cell transplantation for myelofibrosis
@en
P2093
P2860
P1476
Janus kinase inhibitors and allogeneic stem cell transplantation for myelofibrosis
@en
P2093
Damiano Rondelli
Jason Gotlib
Jerald P Radich
Nicolaus M Kröger
Vikas Gupta
P2860
P304
P356
10.1016/J.BBMT.2014.03.017
P577
2014-03-27T00:00:00Z